HealthStream Inc. Q1 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. HealthStream Inc. provides Software-as-a-Service (SaaS) applications for healthcare organizations, focusing on learning, clinical development, credentialing, and scheduling via its hStream technology platform. The company operates as a single consolidated segment.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenues, Net | $81.2 million | $73.5 million |
| Operating Income | $7.5 million | $4.4 million |
| Net Income | $5.9 million | $4.3 million |
| Diluted EPS | $0.20 | $0.14 |
| Adjusted EBITDA | $20.1 million | $16.2 million |
| Cash from Operations | $27.1 million | $27.1 million |
| Cash & Equivalents (End of Period) | $48.7 million | $77.3 million |
| Debt Outstanding | $0 | $0 |
Liquidity: The company holds $48.7 million in cash and cash equivalents and $17.8 million in marketable securities. It maintains a $50.0 million revolving credit facility with no outstanding borrowings as of March 31, 2026.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 10.5% year-over-year, driven by $5.7 million in organic growth and $3.4 million from recent acquisitions (Virsys12 and MissionCare), partially offset by a $1.4 million decline in legacy applications.
- Profitability: Operating income surged 71.6% to $7.5 million, and net income rose 36.4% to $5.9 million. The effective tax rate increased to 24% from 17% in the prior year.
- Acquisitions: The company completed the acquisition of Virsys12 (Oct 2025) and MissionCare Collective (Dec 2025). These deals added significant intangible assets and goodwill, increasing depreciation and amortization expenses by 6%.
- Capital Allocation: The company repurchased $7.5 million of common stock in Q1 2026 (under two separate programs) and paid $1.0 million in dividends. This contrasts with no repurchases in Q1 2025.
Outlook, Risks, and Management Commentary
- Macro Environment: Management cites challenging macroeconomic conditions, including inflation, elevated interest rates, and geopolitical tensions. Specific concern is raised regarding federal budget reconciliation legislation (enacted July 2025) that may reduce Medicaid spending and access to health insurance, potentially causing delays in customer purchasing.
- Sublease Income: The company recorded $0.8 million in sublease income in Q1 2026 from a Nashville office space sublease, with approximately $2.4 million expected for the remainder of 2026.
- Remaining Performance Obligations: Approximately $687 million in revenue is expected to be recognized from remaining performance obligations, with 39% expected over the next 12 months.
- Share Repurchases: A new $10.0 million share repurchase program was authorized in March 2026, terminating in September 2026. The company continued repurchasing shares in Q2 2026.
Investor Verification Checklist
- Acquisition Integration: Verify the revenue contribution and cost synergies from the Virsys12 and MissionCare acquisitions against the $3.4 million reported growth.
- Regulatory Impact: Monitor the actual impact of the July 2025 federal budget legislation on Medicaid-dependent customers and potential contract non-renewals.
- Capital Deployment: Track the execution of the new $10.0 million share repurchase program and the sustainability of the dividend policy given the cash burn from buybacks.
- Deferred Revenue: Analyze the $106.4 million current deferred revenue balance to assess near-term revenue visibility.
- Contingent Consideration: Review the $4.15 million liability for contingent consideration related to acquisitions and potential future cash outflows.